FR2407717A1 - Usage therapeutique nouveau de l'acetyl-1-carnitine - Google Patents

Usage therapeutique nouveau de l'acetyl-1-carnitine

Info

Publication number
FR2407717A1
FR2407717A1 FR7830780A FR7830780A FR2407717A1 FR 2407717 A1 FR2407717 A1 FR 2407717A1 FR 7830780 A FR7830780 A FR 7830780A FR 7830780 A FR7830780 A FR 7830780A FR 2407717 A1 FR2407717 A1 FR 2407717A1
Authority
FR
France
Prior art keywords
carnitine
acetyl
new therapeutic
therapeutic use
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7830780A
Other languages
English (en)
French (fr)
Other versions
FR2407717B1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of FR2407717A1 publication Critical patent/FR2407717A1/fr
Application granted granted Critical
Publication of FR2407717B1 publication Critical patent/FR2407717B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7830780A 1977-11-03 1978-10-30 Usage therapeutique nouveau de l'acetyl-1-carnitine Granted FR2407717A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT51663/77A IT1143611B (it) 1977-11-03 1977-11-03 Applicazione della acetil-carnitina nella terapia delle affezioni cardiache di/tipo anossico,ischemico,cardiotossico e nelle sindromi aritmiche

Publications (2)

Publication Number Publication Date
FR2407717A1 true FR2407717A1 (fr) 1979-06-01
FR2407717B1 FR2407717B1 (OSRAM) 1980-10-03

Family

ID=11275497

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7830780A Granted FR2407717A1 (fr) 1977-11-03 1978-10-30 Usage therapeutique nouveau de l'acetyl-1-carnitine

Country Status (9)

Country Link
JP (1) JPS5476830A (OSRAM)
AU (1) AU524988B2 (OSRAM)
BE (1) BE871753A (OSRAM)
CH (1) CH642847A5 (OSRAM)
DE (1) DE2846335A1 (OSRAM)
FR (1) FR2407717A1 (OSRAM)
IT (1) IT1143611B (OSRAM)
NL (1) NL7810818A (OSRAM)
ZA (1) ZA785998B (OSRAM)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2425855A1 (fr) * 1978-05-15 1979-12-14 Cavazza Claudio Application des acyl-carnitines a un procede therapeutique de traitement de patients uremiques chroniques en traitement hemodialytique periodique et composition liquide de dialyse pour la mise en oeuvre d'un tel procede
FR2448348A1 (fr) * 1979-02-12 1980-09-05 Cavazza Claudio Composition pharmaceutique comprenant une acyl-carnitine pour le traitement du metabolisme cerebral perturbe
FR2448347A1 (fr) * 1979-02-12 1980-09-05 Cavazza Claudio Composition pharmaceutique comprenant une acyl-carnitine pour le traitement des maladies vasculaires peripheriques

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903579A1 (de) * 1978-02-03 1979-08-09 Sigma Tau Ind Farmaceuti Verwendung von acetylcarnitin und anderen acylderivaten des carnitins zur behandlung der hyperlipoproteinaemie und hyperlimpidaemie sowie arzneimittel
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1150396B (it) * 1982-12-09 1986-12-10 Sigma Tau Ind Farmaceuti Impiego di alcanoil l-carnitine per il trattamento terapeutico di miopa tie e distrofie muscolari
JP2006347935A (ja) * 2005-06-15 2006-12-28 Masanori Ogata 炎症性サイトカインの産生が関与する疾患の予防及び／又は治療のための医薬
JP5214249B2 (ja) 2006-11-09 2013-06-19 三菱レイヨン株式会社 ベタインの製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624887A (en) * 1970-03-02 1971-12-07 Bunker Ramo Pin and socket removal tool
US3968241A (en) * 1972-11-06 1976-07-06 Defelice Stephen L Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
JPS531812B2 (OSRAM) * 1972-12-07 1978-01-23
JPS5058213A (OSRAM) * 1973-09-26 1975-05-21

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2425855A1 (fr) * 1978-05-15 1979-12-14 Cavazza Claudio Application des acyl-carnitines a un procede therapeutique de traitement de patients uremiques chroniques en traitement hemodialytique periodique et composition liquide de dialyse pour la mise en oeuvre d'un tel procede
FR2448348A1 (fr) * 1979-02-12 1980-09-05 Cavazza Claudio Composition pharmaceutique comprenant une acyl-carnitine pour le traitement du metabolisme cerebral perturbe
FR2448347A1 (fr) * 1979-02-12 1980-09-05 Cavazza Claudio Composition pharmaceutique comprenant une acyl-carnitine pour le traitement des maladies vasculaires peripheriques

Also Published As

Publication number Publication date
ZA785998B (en) 1980-06-25
IT1143611B (it) 1986-10-22
DE2846335A1 (de) 1979-05-10
AU524988B2 (en) 1982-10-14
AU4131678A (en) 1979-05-17
BE871753A (fr) 1979-03-01
FR2407717B1 (OSRAM) 1980-10-03
CH642847A5 (en) 1984-05-15
NL7810818A (nl) 1979-05-07
JPS649288B2 (OSRAM) 1989-02-16
JPS5476830A (en) 1979-06-19

Similar Documents

Publication Publication Date Title
FR2388556A1 (fr) Application therapeutique de l'acetyl-carnitine-d,1 et d'autres derives acyliques de la carnitine-d,1
FR2401159A1 (fr) Derives de 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidine-4-one, leur procede de preparation et leur activite therapeutique
DE69532216D1 (de) 1-Acetyl-5-Bromo-4,6-Dimethylindolin
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
RU92004423A (ru) Препарат из растений curcuma
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
IT1098059B (it) Nuove preparazioni di microorganismi e procedimento per la loro produzione,come pure l'impiego delle stesse per la decomposizione di prodotti industriali organici di sintesi
PT1137416E (pt) Uso de derivados n-alquilo de cadeia longa de desoxinojirimicina para o fabrico de um medicamento para o tratamento de doencas ligadas ao armazenamento de glicolipidos
FR2407717A1 (fr) Usage therapeutique nouveau de l'acetyl-1-carnitine
FR2401165A1 (fr) Procede de preparation d'analogues de thiadiazolylcephalosporine et nouveaux produits ainsi obtenus, a activite antibacterienne
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
ATE207749T1 (de) Verwendung von raloxifen und dessen analogen zur herstellung eines medikaments zur behandlung von atherosklerose und ischämischer herzerkrankungen
AU647216B2 (en) Improvements in or relating to organic compounds
ES2002398A6 (es) Procedimiento para preparar nuevas enolamidas
DE69327328D1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
RU94044489A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования миелопероксидазной активности
Chojnacki et al. Neuroleptic-induced decrease in platelet MAO activity of schizophrenic patients.
FR2376858A1 (fr) Nouvelles imidazo(1,2-a)quinoxalines substituees en position 4, leur procede de preparation et medicament les contenant
ES468662A1 (es) Procedimiento para producir derivados cefalosporinicos de utilidad terapeutica
Hugo et al. A Positive Wave at the J‐Point of Electrocardiograms of Anaesthetized Baboons (Papio ursinus)
Mielke et al. Antimyotonic therapy with tocainide under ECG control in the myotonic dystrophy of Curschmann-Steinert
BE870646A (fr) Complexes d'inclusion de prostacycline et de derives de prostacycline avec des cyclodextrines, leur preparation et leur application comme medicaments
Arias et al. Sudden cardiac death during Holter recording in a patient with vasospastic angina
DE69713648D1 (de) Benzopyranderivate und ihre Verwendung zur Behandlung von Herzkrankheiten
FR2410640A1 (fr) Derives de phenoxyalcanolamines, leur preparation et leurs utilisations therapeutiques